8-KThe WireRoutine
Shareholder Vote
Filed Jun 12, 2026 · 17d ago · Accession 0001193125-26-269387
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- 8-K
- Filing date
- Jun 12, 2026
- Report date
- Jun 11, 2026
- Document
- janx-20260611.htm
- Size
- 173 KB